GlassScriptPhysician profile
Seth R Stoller
NPI 1467408583
$35,208.77
in general payments reported to CMS, 2019-2025
12 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,132 · 2020: $19K · 2021: $9,260 · 2022: $27.13 · 2023: $56.96 · 2024: $16.27 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $21,975.45 | 2019-2021 | |
| Allergan, INC. | $9,211.89 | 2020-2021 | |
| Abbvie INC. | $3,743.89 | 2021-2024 | Qulipta |
| Mml US, INC. | $119.10 | 2025 | Reactiv8 |
| Supernus Pharmaceuticals, INC. | $40.10 | 2019-2020 | |
| Grifols USA, LLC | $21.49 | 2023 | Prolastin-C Liquid |
| Lexicon Pharmaceuticals, INC. | $20.36 | 2023 | Inpefa |
| Boston Scientific Corporation | $19.35 | 2020 | |
| Merz North America, INC. | $15.65 | 2019 | |
| Amgen INC. | $14.93 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.76 | 2019 | |
| Lundbeck LLC | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Stoller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.